Advait Gupta

5682 POSTS
Advait is our expert writer and manager for the Artificial Intelligence category. His passion for AI research and its advancements drives him to deliver in-depth articles that explore the frontiers of this rapidly evolving field. Advait's articles delve into the latest breakthroughs, trends, and ethical considerations, keeping readers at the forefront of AI knowledge.

Exclusive articles:

SoftBank CEO Believes AI Will Change Human Life Within 30 Years, But Can’t Stop Using ChatGPT

SoftBank CEO Masayoshi Son embraces AI with OpenAI's ChatGPT. Despite investment unit's loss, he believes AI will change human lives. Read more here.

What Comes Next for BlackRock?

BlackRock, the world's largest asset manager with over $9 trillion in assets, faces challenges such as the departure of its CEO Larry Fink and significant changes within the company. Read on to learn more.

FireFly AI: The Bing Chat Competitor That Could Emerge Victorious

Discover how Adobe's AI platform, Firefly, could potentially outshine Microsoft's Bing Chat as the go-to AI tool in Windows 11. See how Firefly gives more options and inspiration to content creators, making it an indispensable tool for improving their projects.

AI-Powered Teddy Bears to Read Personalized Bedtime Stories to Children in 5 Years, Says Major Toy Producer CEO

AI teddy bears that read personalized bedtime stories to kids may become the norm in 5 years, says toymaker CEO. But, privacy and security concerns must be taken seriously before releasing these toys to the market.

Christopher Nolan’s Journey to Embrace AI: From Worries to Love

Learn more about Christopher Nolan's upcoming biopic on J. Robert Oppenheimer, the father of the atomic bomb, and how it explores the current state of the world.

Breaking

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.
spot_imgspot_img